Efficacy of venlafaxine in depressive illness in general practice

Acta Psychiatrica Scandinavica

Volumn 95, Issue 6, 1997, Pages 485-493

  Lecrubier, Y ^a   Bourin, M ^b   Moon, C A L ^c   Schifano, F ^d   Blanchard, C ^e   Danjou, Ph ^e   Hackett, D ^e,f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c South West Clinical Research Group   (United Kingdom)

^d Centro Antidroga   (Italy)

^e Searle European Clinical R and D   (France)

^f Wyeth Ayerst Research European CR and D Department   (France)

Author keywords

Depression; General practice; Imipramine; Serotonin noradrenaline reuptake inhibitor; Venlafaxine

Indexed keywords

IMIPRAMINE; PLACEBO; VENLAFAXINE;

ABDOMINAL PAIN; ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; GASTROENTERITIS; GENERAL PRACTICE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SOMNOLENCE; SWEATING; VERTIGO; XEROSTOMIA;

EID: 0030948638     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb10136.x     Document Type: Article

References (22)

1. RASMUSSEN JGC. Venlafaxine: a new or another antidepressant? Primary Care Psychiatry 1995: 1: 187-195.
2. SIRELING L, FREELING P, PAYKEL ES, RAO BM. Depression in general practice: case thresholds and diagnosis. Br J Psychiatry 1985: 147: 113-119.
3. SCHURMAN RA, KRAMER PD, MITCHELL JB. The hidden mental health network. Arch Gen Psychiatry 1985: 42: 89-94.
4. RICKELS K, GORDON PE, WHELLER-JENKINS B, PERLOFF M, SACHS T, STEPANSKY W. Drug treatment of depressive illness: amitriptyline and chlordiazepoxide in two depressive populations. Dis Nerv Syst 1970: 31: 30-42.
5. THOMSON J, RANKIN H, ASHCROFT GW, YATES CM, MCQUEEN JK, CUMMINGS SW. The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline and a combination of L-tryptophan and amitriptyline with placebo. Psychol Med 1982: 12: 741-751.
6. BLASHKI TG, MOWBRAY R, DAVIES B. Controlled trial of amitriptyline in general practice. Br Med J 1971: 1: 133-138.
7. FAHY TJ. Pathways of specialist referral of depressed patients from general practice. Br J Psychiatry 1974: 124: 231-239.
8. JOHNSON DAW, MELLOR V. The severity of depression in patients treated in general practice. J R Coll Gen Pract 1977: 27: 419-422.
9. PAYKEL ES, HOLLYMAN JA, FREELING P, SEDGWICK P. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Dis 1988: 14: 83-95.
10. MONTGOMERY SA, ASBERG M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979: 30: 382-389.
11. GUY W, ed. ECDEU assessment manual for psychopharmacology, revised edn. DHEW Publication No. (ADM) 76-338. Rockville, MD: National Institute of Mental Health, 1976.
12. TYRER R, OWEN RT, CICCHETTI DV. The brief scale for anxiety: a subdivision of the Comprehensive Psychopathological Rating Scale. J Neurol Neurosurg Psychiatry 1984: 47: 970-975.
13. RASKIN A, SCHULTERBRANT J, REATIG N et al. Replication of factors of psychopathology in interview, ward behaviour and self-report ratings of hospitalized depressives. J Nerv Ment Dis 1969: 148: 87-98.
14. LEONARD RD, LIPMAN RS, RICKELS K et al. The Hopkins Symptom Checklist (HSCL): a measure of primary symptom dimensions. In: PICHOT P et al., ed. Psychological measurements in psychopharmacology: Mod Probl Pharmacopsychiatr. Basel: Karger, 1974: 99-110.
15. WEISSMAN MM, BOTHWELL S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 1976: 33: 1111-1115.
16. DIERICK M, RAVIZZA L, REALINI R, MARTIN A. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in out-patients. Prog Neuropsychopharmacol Biol Psychiatry 1996: 20: 57-71.
17. KAHN RJ, MCNAIR DM, LIPMAN RS et al. Imipramine and chlordiazepoxide in depressive and anxiety disorders. Arch Gen Psychiatry 1986: 43: 79-85.
18. BIELSKY RJ, FRIEDEL RO. Prediction of tricyclic antidepressant response. Arch Gen Psychiatry 1976: 33: 1479-1489.
19. DELISIO G, MAREMMANI I, PERUGI G et al. Impairment of work and leisure in depressed out-patients: a preliminary communication. J Affect Dis 1986: 10: 79-84.
20. PERUGI G, MAREMMANI I, MCNAIR DM et al. Differential changes in areas of social adjustment from depressive episodes through recovery. J Affect Dis 1988: 15: 39-43.
21. KELLER MG, LAVORI PW, MUELLER TI et al. Time to recovery, chronicity, and levels of psychopathology in major depression. Arch Gen Psychiatry 1992: 49: 809-816.
22. DANJOU P, HACKETT H. Safety and tolerance profile of venlafaxine. Int Clin Psychopharmacology 1995: 10 (Suppl.2): 15-20.